Stocks and Investing
Stocks and Investing
Mon, January 8, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Fri, January 5, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Jailendra Singh Downgraded (AGL) to Hold and Decreased Target to $10 on, Jan 5th, 2024
Jailendra Singh of Truist Securities, Downgraded "agilon health, inc." (AGL) to Hold and Decreased Target from $23 to $10 on, Jan 5th, 2024.
Jailendra has made no other calls on AGL in the last 4 months.
There are 6 other peers that have a rating on AGL. Out of the 6 peers that are also analyzing AGL, 2 agree with Jailendra's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Jamie Perse of "Goldman Sachs" Downgraded from Strong Buy to Hold on, Monday, December 11th, 2023
- George Hill of "Deutsche Bank" Downgraded from Strong Buy to Hold and Decreased Target to $12 on, Tuesday, November 21st, 2023
These are the ratings of the 4 analyists that currently disagree with Jailendra
- Constantine Davides of "JMP Securities" Initiated at Buy and Held Target at $18 on, Wednesday, December 6th, 2023
- Bill Sutherland of "Benchmark" Maintained at Strong Buy with Decreased Target to $22 on, Wednesday, November 15th, 2023
- Stephen Baxter of "Wells Fargo" Maintained at Buy with Decreased Target to $16 on, Monday, November 13th, 2023
- Sean Dodge of "RBC Capital" Maintained at Buy with Decreased Target to $23 on, Friday, November 3rd, 2023
Contributing Sources